| 000 | 01773 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513125907.0 | ||
| 264 | 0 | _c19971023 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0272-6386 | ||
| 024 | 7 |
_a10.1016/s0272-6386(97)90307-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaughan, W J | |
| 245 | 0 | 0 |
_aA 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. _h[electronic resource] |
| 260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cOct 1997 |
||
| 300 |
_a495-500 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAnabolic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNandrolone _xadministration & dosage |
| 650 | 0 | 4 | _aNandrolone Decanoate |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLiss, K A | |
| 700 | 1 | _aDunn, S R | |
| 700 | 1 | _aMangold, A M | |
| 700 | 1 | _aBuhsmer, J P | |
| 700 | 1 | _aMichael, B | |
| 700 | 1 | _aBurke, J F | |
| 773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 30 _gno. 4 _gp. 495-500 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0272-6386(97)90307-3 _zAvailable from publisher's website |
| 999 |
_c9301521 _d9301521 |
||